Moderna seeks full US approval for COVID-19 shots

Credit: Citrix / CC0 Public Domain

Moderna said Tuesday that she was applying for full US approval of the COVID-19 vaccine for people over the age of 18, and joined Pfizer, which made the same application last month.

Is vaccine Beginning December 18, 2020, it will be available under an “Emergency Use Authorization” aimed at making life-saving medications available as soon as possible.

In the United States, more than 124 million vaccines have been given.

“We are pleased to announce this important step in the United States. Regulatory process For the Biopharmaceutical License Application (BLA) for our COVID-19 vaccine, “said Stephane Bancel, CEO of the company.

“We look forward to working with the FDA and will continue to submit data from Phase 3 trials to complete rolling submissions.”

Last week, Moderna announced that its vaccine was very effective in adolescents and would soon seek approval for children aged 12 to 17 years.

Two-shot therapy is about 90% effective against symptomatic COVID-19 and 95% effective against serious illness.

Moderna says the COVID vaccine is “very effective” in adolescents

© 2021 AFP

Quote: Moderna took a COVID-19 shot (June 1, 2021) from on June 1, 2021. Seeking full US approval.

This document is subject to copyright. No part may be reproduced without written permission, except for fair trade for personal investigation or research purposes. The content is provided for informational purposes only.

Moderna seeks full US approval for COVID-19 shots

Source link Moderna seeks full US approval for COVID-19 shots

Show More

Related Articles

Back to top button